Hypera (HYPE3) Q4 2024 earnings summary

Executive summary

• Net revenue for 2024 was R$7,442.5 million, down 6% year-over-year, with a sharper 18% drop in Q4 sales versus the prior year.

• Sell-out grew 9.3% in 2024, with 25.5% growth in the non-retail segment and 8.1% in retail, outpacing the market in non-retail by nearly 20 percentage points.

• Net income from continuing operations declined 19.3% to R$1,333.0 million, with Q4 net income down 74.2% year-over-year.

• Over R$2.3 billion invested in marketing, innovation, and production/distribution capacity, with more than 50 product launches and expansion of the Anápolis distribution center.

• Recognized for sustainability and governance, with inclusion in FTSE4Good, B3 IDIVERSA, and S&P Global Sustainability Yearbook, and creation of a Governance and Sustainability Committee.

Financial highlights

• Gross margin was 58.9% for 2024 (R$4,381.0 million), down 4.2 percentage points year-over-year; Q4 gross margin was 52.0%.

• EBITDA margin from continuing operations was 28.2% for 2024 (R$2,101.0 million), with Q4 margin at 9.1%.

• Operational cash flow reached a record R$2,539.6 million, up 6% year-over-year, and free cash flow was R$1,739 million.

• Net debt stood at R$7,501.1 million at year-end, with a dividend payout of R$738.9 million and a 6.5% yield.

• Net financial expenses improved to R$840.7 million, R$167.6 million lower than 2023, due to lower Selic rates.

Outlook and guidance

• Working capital optimization is expected to normalize by May 2024, with full alignment and improved returns on invested capital by 2025.

• Q2 results will still reflect adjustment effects, but normalization and margin recovery are expected in the second half of 2024.

• Pipeline prepared for patent expirations between 2026-2030, targeting a $10 billion market opportunity, especially in chronic and preventive treatments.

• Margins expected to remain compressed in H1 2024, with recovery anticipated in H2 as fixed costs become better absorbed.

• Forward-looking statements depend on market conditions, regulations, and macroeconomic factors.